Fact Sheet
Digital Health and MedTech in Pakistan: Opportunities for Swiss Exporters
Swiss Business Council, Karachi
Apr 28, 2026
Pakistan's MedTech market, valued at USD 500–600 million, is expanding as the country modernizes its healthcare infrastructure to serve a population of over 240 million. With more than 90 percent of medical devices imported, the market offers concrete entry points for Swiss suppliers of diagnostic systems, laboratory equipment, medical imaging, and digital health solutions.
Rising healthcare spending, the expansion of private hospitals and diagnostic laboratories in Karachi, Lahore, and Islamabad, and government initiatives such as the Sehat Sahulat Programme are driving steady demand for advanced medical technologies. Swiss companies are well positioned in segments where precision engineering and regulatory compliance are decisive, including molecular diagnostics, automated laboratory systems, intensive care technologies, and telemedicine platforms. Market access requires registration with the Drug Regulatory Authority of Pakistan (DRAP), which can involve extended administrative timelines and makes early preparation and local support essential.
Our new report provides Swiss SMEs with a structured overview of market size, regulatory requirements, key players, and upcoming industry events in 2026. Switzerland Global Enterprise and the Swiss Business Council in Karachi support Swiss companies with market insights, compliance guidance, and introductions to qualified local partners to facilitate a successful entry into Pakistan's healthcare sector.
